TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: total steps/day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: infectious episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: red cell aggregation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: body mass index (BMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement on Nutt's rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fasting glycaemia at delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: LGA (Large for Gestational Age) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight Z-score deterioration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of new infections
Endpoint domain: Adverse events/effects
Primary endpoint: Likelihood of earlier discharge from PICU alive
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of patients with chest pain prior to MI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for interventional therapies
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Culture positivity rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ESwab sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ESwab specificity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intentions to undertake recommended levels of physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improved sexual and relationship functioning
Endpoint domain: Life impact
Endpoint subdomain: Relationship functioning
Primary endpoint: Overall efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: drug consumption during the second year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visibility of anatomic structures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Father-child communication patterns
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Adherence to antibiotic guidelines for CAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PB level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ashworth score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: SGI
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of new primary NMSCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Time to new NMSC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Total NMSC counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Improvement in psychological health-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in social health-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: operation time per joint
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: dislocation recurrence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feelings of hunger and appetite
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Worry symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MRC score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fatigue improvement on CRDQ
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Satiety score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 24-hour urinary potassium excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction of pigmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Reduction of thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Any event
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in gingival bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of anterior atlantoaxial subluxation (aAAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incidence of atlantoaxial impaction (AAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incidence of subaxial subluxation (SAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: T-EAT-10 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Water swallowing capacity and volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal voluntary contraction values of suprahyoid muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Maxillary incisor inclination (U1-SN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain scores at 12 h and 24 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diastolic left-ventricular function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Decreasing hematuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Urinary outcomes
Primary endpoint: Improving immune function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Radiographic progression-free survival at 24 months
Endpoint domain: Mortality/survival
Primary endpoint: initial postoperative back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of nausea and vomiting experienced during chemotherapy treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Standardized Mortality Ratio (SMR)
Endpoint domain: Mortality/survival
Primary endpoint: Change in seated diastolic blood pressure (SeDBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in seated systolic blood pressure (SeSBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Blood pressure goal rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in SANS total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average cognition z score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall OA pain intensity in the target hand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from angina at discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for further interventions within one year
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Q-wave myocardial infarction during procedure
Endpoint domain: Adverse events/effects
Primary endpoint: insomnia symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Independent activity of daily living (IADL) score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: development of metabolic risk factors for cardiovascular disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: exercise-induced cardiac abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: comorbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma concentrations of triacylglycerols
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: VLDL apo B production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Blister formation
Endpoint domain: Adverse events/effects
Primary endpoint: 1-year death
Endpoint domain: Mortality/survival
Primary endpoint: major adverse cardiac event (MACE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Patient satisfaction with fetal telecardiology
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduced travel times
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduced days off work
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Cognitive enhancement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Peak Maximal Force (PMAX)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: HDL concentration increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: clinical variables
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: outcome measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: radiographic evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical Fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: General Fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Complaints of dizziness or fatigue
Endpoint domain: Adverse events/effects
Primary endpoint: Ear dryness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Salivary acetaldehyde concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parasympathetic reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved knowledge for healthy food choices
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improved intentions for healthy food choices
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improved self-efficacy for healthy food choices
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: OKS score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: KOOS Sport and Recreation score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Serum parathyroid hormone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incident atrial fibrillation
Endpoint domain: Mortality/survival
Primary endpoint: Improvement of symptoms (dyspnea, number of coughs, rescue β(2)-adrenergic agonist-free days)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in overall side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Radiotherapy initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Radiotherapy interruption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Radiotherapy modification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Early termination of Radiotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Carpometacarpal joint angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Short term survival without rebleeding
Endpoint domain: Mortality/survival
Primary endpoint: Blood transfusion requirement
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Nitrate and nitrite plasma concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum antioxidant concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean goblet cell density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: McMonnies dry eye symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: nasolabial wrinkles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: crow's feet wrinkle depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Pain intensity while resting or chewing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Experience of anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: BMD in the lumbar spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BMD in the total hip
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical benefit of rotablator treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Post-Lumbar Puncture Headache (PLPH)
Endpoint domain: Adverse events/effects
Primary endpoint: Post-Lumbar Puncture Back Pain (PLPBP)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in median frequency of EMG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Onset of fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Arrhythmia free status without antiarrhythmics
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Inducibility of sustained AF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: AFCL prolongation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of cesarian sections for fetal distress
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Mean pH at birth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of variable fetal heart rate decelerations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mood symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall complication rate (hemorrhages and thromboembolic events)
Endpoint domain: Adverse events/effects
Primary endpoint: Downregulation of miR-142-3p
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incisor adduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: forward moving distance of U6
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood alcohol concentration (BAC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of responders with at least a 30% reduction in PANSS total scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart rate variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: risk of stroke and vascular death
Endpoint domain: Mortality/survival
Primary endpoint: Seroconversion
Endpoint domain: Mortality/survival
Primary endpoint: Unprotected receptive anal intercourse
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: treatment-related toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Decrease in inflammatory lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Interrater reliability of MRI readings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of amenorrhea at 12-months post-ablation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of acute respiratory distress syndrome
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of intestinal paralysis
Endpoint domain: Adverse events/effects
Primary endpoint: Child body mass index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median direct costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Gingival Bleeding Index (GBI) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: S. mutans counts in saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: Microbial outcomes
Primary endpoint: WM volume change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intubation difficulty scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cormack and Lehane glottic view
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uptake of the IUD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endothelial cell loss postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serious corneal edema
Endpoint domain: Adverse events/effects
Primary endpoint: Probability of continuing diarrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rate of treatment failure or death
Endpoint domain: Mortality/survival
Primary endpoint: Rate of grade 3/4 toxic effects
Endpoint domain: Adverse events/effects
Primary endpoint: Subjective responsivity to stress scripts (crave cocaine Visual Analog Scale)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: cellular yield
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensitivity for the detection of cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: mean pain scores during deep tissue dissection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rescue doses of opioid
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: rescue doses of local anesthetic
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Diabetes knowledge scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: leukocyte subset distributions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: ROS production by stimulated PMNs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: cytokine production capacity of leukocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: automated driving performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of discrepancies and prescription errors
Endpoint domain: Adverse events/effects
Primary endpoint: Height increase standard deviation scores (SDS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for electric cardioversion as therapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Size of the pulmonary artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ultrasound-needle angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in number of regular medicines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: smooth pursuit gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pro-saccade latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anti-saccade latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of the ethics review process (ERP)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Confusion
Endpoint domain: Adverse events/effects
Primary endpoint: Dry mouth
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of recurrent resting angina
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: need for emergency surgical revascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: risk of adverse cardiovascular event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overnight decrease in leg fluid volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morning upper-airway cross-sectional area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma viral load <50 copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to successful intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Mean difficulty score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Probability of pregnancy during 6 months of typical use
Endpoint domain: Mortality/survival
Primary endpoint: plasma cortisol response to IPS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Complete responses (no emetic episodes and no escape antiemetic medication requirements)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nausea VAS score < 5 mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Debridement discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes